
New Cancer Therapy: FDA grants priority review of glofitamab for lymphoma
New Cancer Therapy: The US Food and Drug Administration (FDA) has granted the review of glofitamab. It will be reviewed for relapsed or refractory large […]
New Cancer Therapy: The US Food and Drug Administration (FDA) has granted the review of glofitamab. It will be reviewed for relapsed or refractory large […]
New Cancer Therapy: The recent research publication in the Proceedings of the National Academy of Sciences has presented the concept of predicting breast cancer treatment […]
Global Healthcare trends: A meeting took place on 30 December between WHO and China. It focus on discussing the current situation of China due to […]
Healthcare trends 2022: “While patients with more advanced HIV are known to be at greater risk for COVID-19. It is still a question whether vaccination […]
Healthcare trends 2022: Health ministry of India has advised the citizens to take all preventive measures against COVID-19. The measures include getting vaccinated and wearing […]
Healthcare trends 2022: Even after Three years of COVID-19 outbreak in China, the country seems to be at its worst. Millions of the citizens are […]
Clinical Drug Development Process: A Phase I/II trial of monoclonal antibody (mAb) AOC 1001 is successfully done aiming for the targeted delivery of siRNA into […]
Biologics development: The first ever use of base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy was done on a thirteen-year-old patient suffering from […]
Clinical Phases of Drug Development: Among the different clinical phases of drug development, a phase II trial of Dostarlimab was done and is presented in […]
Healthcare technology news: According to the findings published in the British Journal of Ophthalmology the retina’s network of the veins and arteries can help in […]
Copyright © 2023 | WordPress Theme by MH Themes